Singapore, Singapore

Matthew Cove


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Profile: Matthew Cove and His Pioneering Patent in Carbon Dioxide Removal

Introduction: Matthew Cove is an innovative inventor based in Singapore, SG, who has made significant strides in the medical field with his groundbreaking patent. His work focuses on a vital method for reducing carbon dioxide concentration in blood plasma, which holds substantial implications for patient care and treatment processes.

Latest Patents: Matthew Cove holds a patent for a novel approach titled "Removal of Carbon Dioxide via Dialysis." This method involves extracting blood from a patient to treat the blood plasma by flowing it on one side of a semi-permeable membrane while concurrently administering a dialysate on the opposite side. The dialysate is formulated to have a lower concentration of bicarbonate than the blood plasma, thereby ensuring that the pH level of the plasma remains stable, with only a minimal variation during treatment.

Career Highlights: Matthew's career is marked by a commitment to enhancing medical technologies and improving patient outcomes. His contribution through this patent not only showcases his technical expertise but also reflects his dedication to advancing medical practices in the field of dialysis.

Collaborations: Throughout his career, Matthew has collaborated with esteemed colleagues such as John Alston Kellum and William J Federspiel. Their collective insights and expertise have undoubtedly enriched the developmental phase of his innovative ideas, leading to successful research outcomes.

Conclusion: With his patent for the removal of carbon dioxide via dialysis, Matthew Cove exemplifies the spirit of innovation in the medical industry. His efforts in collaboration with prominent researchers not only advance science but also contribute to the well-being of patients who require these critical treatment options. As he continues his work at the University of Pittsburgh, the potential for further breakthroughs in medical technology remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…